Lizzy241- I know a few posters went to the Adcom. Maybe they can share their views? I watched it online and was so disappointed in the panel. Some of the panels concerns were like they only read MRC's nonsense. That in their eyes made Vascepa controversial. The panel might of voted the right way but at least in their comments they had caveats. In my opinion if there was no adcom, there would be fewer warnings in the ads.
Market Data 
Markets 
AI
